Issue 10/2004
Content (8 Articles)
A phase II trial of FUdR in patients with advanced pancreatic cancer
Bach Ardalan, Mayra Lima
Effects of the angiotensin-I converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells
Ryuji Yasumatsu, Torahiko Nakashima, Muneyuki Masuda, Aya Ito, Yuichiro Kuratomi, Takashi Nakagawa, Shizuo Komune
Methylenetetrahydrofolate reductase C677T polymorphism and predisposition towards esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population
Jianhui Zhang, Rainer B. Zotz, Yan Li, Rui Wang, Sybille Kiel, Wolfgang A. Schulz, Denggui Wen, Zhifeng Chen, Liwei Zhang, Shijie Wang, Helmut E. Gabbert, Mario Sarbia
Quality of adjuvant CMF chemotherapy for node-positive primary breast cancer: a population-based study
Michael Schaapveld, Elisabeth G. E. de Vries, Winette T. A. van der Graaf, Renée Otter, Pax H. B. Willemse
Potent antitumoral efficacy of a novel replicative adenovirus CNHK300 targeting telomerase-positive cancer cells
C.-Q. Su, J. Sham, H.-B. Xue, X.-H. Wang, D. Chua, Z.-F. Cui, L.-H. Peng, L.-F. Li, L.-H. Jiang, M.-C. Wu, Q.-J. Qian
Gefitinib (‘IRESSA’, ZD1839) inhibits EGF-induced invasion in prostate cancer cells by suppressing PI3 K/AKT activation
Lorella Bonaccorsi, Sara Marchiani, Monica Muratori, Gianni Forti, Elisabetta Baldi
Differential proteomic analysis of human hepatocellular carcinoma cell line metastasis-associated proteins
Jie-Feng Cui, Yin-Kun Liu, Bo-Shen Pan, Hai-Yan Song, Yu Zhang, Rui-Xia Sun, Jie Chen, Ju-Tao Feng, Zhao-You Tang, Yan-Ling Yu, Hua-Li Shen, Peng-Yuan Yang
Tumour lysis syndrome in multiple myeloma after bortezomib (VELCADE) administration
Evangelos Terpos, Marianna Politou, Amin Rahemtulla